However, on November 20th, Min Heejin issued a statement confirming her departure from HYBE, effectively ending any possibility of her returning as Adore's CEO. Following this, speculation has grown that New Genes might also part ways with Adore to join Min Heejin in a new venture.

然而，11 月 20 日，閔熙真發表聲明，確認她將離開 HYBE，這實際上斷絕了她重返 Adore 擔任首席執行官的可能性。 此後，人們紛紛猜測 New Genes 可能也會與 Adore 分道揚鑣，與閔熙真一起投入新的事業。

If New Genes decides to leave Adore and align with Min Heejin, they will likely face a legal dispute over their exclusive contracts.

如果 New Genes 決定離開 Adore，與 Min Heejin 結盟，他們很可能會面臨專屬合同的法律糾紛。

This could delay their activities indefinitely during the legal proceedings. Even if New Genes wins the contract termination case, the issue of trademark rights remains.

這可能會在法律訴訟期間無限期地拖延他們的活動。 即使新基因公司在合同終止案中勝訴，商標權問題依然存在。

Currently, the New Genes trademark is owned by Adore.

目前，"新基因 "商標歸 Adore 公司所有。

Legal experts predict that even with a favorable ruling on contract termination, reclaiming the trademark would be a significant challenge.

法律專家預測，即使對合同終止做出有利的裁決，收回商標也將是一個巨大的挑戰。

Additionally, if New Genes fails to terminate their contracts, the estimated penalty for leaving Adore is expected to reach hundreds of billions of won. According to the Fair Trade Commission's standard exclusive contract terms, penalties are calculated by multiplying the monthly average revenue of the past two years by the number of months remaining in the contract.

此外，如果 New Genes 無法終止合同，離開 Adore 的違約金預計將高達數千億韓元。 根據公平貿易委員會的標準獨家合同條款，違約金的計算方法是將過去兩年的月平均收入乘以合同剩餘月數。

Adore reported a revenue of $110.3 billion won last year, and New Genes has five years left on their contract.

Adore 去年的收入為 1 103 億韓元，而 New Genes 的合同還剩五年。

As such, the estimated penalty for New Genes could range from $400 to $600 billion won. Meanwhile, Min Heejin continues to express her affection for New Genes, sharing promotional content for the group on her personal SNS even after resigning from Adore.

是以，New Genes 的罰款金額估計在 4000 億韓元至 6000 億韓元之間。 與此同時，閔熙真繼續表達她對新基因的喜愛，即使在從 Adore 辭職後，她仍在個人 SNS 上分享新基因的宣傳內容。

On November 25th, Min Heejin filed breach of trust charges against HYBE's chief communications officer, CCO Park Tae-hee, and PR Director Jo, with the Seoul Yongsan Police Station. Earlier, on November 22nd, she also filed defamation lawsuits under the Information and Communications Network Act against officials at HYBE's subsidiary Belift Lab, including CEO Kim Tae-ho, Vice CEO Choi Yun-hyuk, and others.

11 月 25 日，Min Heejin 向首爾龍山警察署提交了針對 HYBE 首席宣傳官、首席運營官 Park Tae-hee 和公關總監 Jo 的失信指控。 此前的 11 月 22 日，她還根據《資訊通信網法》對 HYBE 子公司 Belift Lab 的首席執行官 Kim Tae-ho、副首席執行官 Choi Yun-hyuk 等人提起了誹謗訴訟。

Additionally, she has launched a $5.1 billion damages lawsuit against Belift Lab.

此外，她還對 Belift Lab 提起了 51 億美元的損害賠償訴訟。